Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Trial of PEHRG214 in HIV-Infected Patients

This study has been terminated.
(Difficulty recruiting eligible patients in timely fashion)
Sponsor:
Information provided by:
Virionyx Corporation Limited
ClinicalTrials.gov Identifier:
NCT00385567
First received: October 1, 2006
Last updated: August 24, 2010
Last verified: August 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2008
  Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)